CirCode Biomed
China - ShanghaiBiotechnology
Focus: CirCode Biomed is an RNA therapeutics company focused on gene therapy, currently in early-stage development with one Phase 1 program. The company is based in Shanghai and operates as a pre-revenue biotech entity.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Open Jobs
0
About CirCode Biomed
AI assessmentNot HiringNo open roles listed right now. Follow CirCode Biomed to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
1 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
HM2002 injection
Ischaemic Heart DiseaseClinical Trials (1)
NCT06621576First-in-Human Pilot Study of Epicardial Circular RNA-HM2002 Injection in CABG for Ischemic Heart Failure
Phase 1Help build intelligence for CirCode Biomed
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.